Wednesday, July 18, 2018

Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.


from Reuters: Health News https://ift.tt/2L36EpB

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Suicide is the only cause of death that is higher among doctors than the general population, according to two Canadian physicians who coauthored an information sheet about physician suicide. from Reute… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Younger boys who play lacrosse are more likely to get injured and sustain concussions than high school or college players, a U.S. study suggests. from Reuters: Health News https://reut.rs/2VzY7jq … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Patients who see their doctors in the morning are a lot more likely to be referred for screenings for breast and colon cancer than patients with end-of-the-day appointments, a new study suggests. from … Read More
  • LATEST HEALTH NEWSNovartis AG is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal muscular atrophy (SMA), a treatment that could cost more than a million dollars, but the gesture comes with stri… Read More
  • LATEST HEALTH NEWS(This April 29 story corrects seventh bullet point to remove erroneous mention of California, which eliminated all non-medical exemptions in 2015) from Reuters: Health News https://reut.rs/2WcvvZH … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner